Second-line chemotherapy after disease progression following first-line FOLFOXIRI in advanced pancreatic cancer patients

被引：0
|
作者：
Vasile, E. [1 ]
Vivaldi, C. [1 ]
Fornaro, L. [1 ]
Caparello, C. [1 ]
Musettini, G. [1 ]
Pasquini, G. [1 ]
Catanese, S. [1 ]
Lencioni, M. [1 ]
Ricci, S. [1 ]
Falcone, A. [1 ]
机构：
[1] AOU Pisana, Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
L26
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [21] Beneficial trends of second-line chemotherapy in advanced pancreatic cancer
    Silva, Milton Jose B.
    Maia, Joyce Maria L.
    Ribeiro, Adriana Regina G.
    Chinen, Ludmilla T. D.
    Paiva, Tadeu Ferreira, Jr.
    Padua, Fernando Vidigal
    Ismael Pinto, Flavio Augusto
    Santos, Elizabeth Santana
    Mello, Celso Lopes
    Campanha, Daniel
    Rodrigues Pereira, Augusto Akikubo
    Fanelli, Marcello Ferretti
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Efficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
    Ota, T.
    Kirita, K.
    Udagawa, H.
    Umemura, S.
    Matsumoto, S.
    Yoh, K.
    Niho, S.
    Goto, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [23] FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
    Angélique Vienot
    Hortense Chevalier
    Clément Bolognini
    Elisabeta Gherga
    Elodie Klajer
    Aurélia Meurisse
    Marine Jary
    Stefano Kim
    Christelle d’Engremont
    Thierry Nguyen
    Fabien Calcagno
    Hamadi Almotlak
    Francine Fein
    Meher Nasri
    Syrine Abdeljaoued
    Anthony Turpin
    Christophe Borg
    Dewi Vernerey
    World Journal of Gastrointestinal Oncology, 2020, 12 (03) : 332 - 346
  • [24] FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
    Vienot, Angelique
    Chevalier, Hortense
    Bolognini, Clement
    Gherga, Elisabeta
    Klajer, Elodie
    Meurisse, Aurelia
    Jary, Marine
    Kim, Stefano
    d'Engremont, Christelle
    Nguyen, Thierry
    Calcagno, Fabien
    Almotlak, Hamadi
    Fein, Francine
    Nasri, Meher
    Abdeljaoued, Syrine
    Turpin, Anthony
    Borg, Christophe
    Vernerey, Dewi
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (03) : 332 - 346
  • [25] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer
    Otsuka, Ryo
    Iwasa, Satoru
    Yanai, Takako
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hashimoto, Hironobu
    Sekiguchi, Masatoshi
    Makino, Yoshinori
    Boku, Narikazu
    Yamaguchi, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (04) : 595 - 601
  • [26] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer
    Ryo Otsuka
    Satoru Iwasa
    Takako Yanai
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Hironobu Hashimoto
    Masatoshi Sekiguchi
    Yoshinori Makino
    Narikazu Boku
    Masakazu Yamaguchi
    International Journal of Clinical Oncology, 2020, 25 : 595 - 601
  • [27] Second-line chemotherapy for patients with advanced gastric cancer
    Daisuke Takahari
    Gastric Cancer, 2017, 20 : 395 - 406
  • [28] Second-line chemotherapy for patients with advanced gastric cancer
    Takahari, Daisuke
    GASTRIC CANCER, 2017, 20 (03) : 395 - 406
  • [29] Impact of Clinical Response to First-Line Chemotherapy on Gastric Cancer Patients Treated with Second-Line and Third-Line Chemotherapy
    Kodera, Yasuhiro
    Ito, Yuichi
    Ohashi, Norifumi
    Nakayama, Goro
    Koike, Masahiko
    Fujiwara, Michitaka
    Nakao, Akimasa
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 1041 - 1045
  • [30] Potential Treatment Options After First-Line Chemotherapy for Advanced NSCLC: Maintenance Treatment or Early Second-Line?
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Ferrara, Marianna Luciana
    Bareschino, Maria Anna
    Schettino, Clorinda
    Sacco, Paola Claudia
    Ciardiello, Fortunato
    ONCOLOGIST, 2009, 14 (02): : 137 - 147
12345